IP Library Granted Patent US 9,469,675
Granted Patent B2
US 9,469,675 · App. 13/997,031 · Granted Oct 18, 2016

Anti-inflammatory proteins and methods of preparation and use thereof

Inventors: Amanda Bean (Hamilton, NZ); Peter Molan (Hamilton, NZ); Ray Cursons (Hamilton, NZ); Richard Wilkins (Lyttelton, NZ)
Assignee: ManukaMed Limited
C07K14/43572G01N21/64G01N33/15G01N33/68A61K38/00G01N2333/43565
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,469,675
App. No.
13/997,031
Granted
Oct 18, 2016
Kind
B2
Abstract

The present disclosure relates to anti-inflammatory proteins, their uses, methods of preparation and methods of their detection. In particular, the invention relates to major royal jelly proteins modified by methyglyoxal and fragments thereof from manuka honey.

Claims (17)

1. A method of identifying (i) anti-inflammatory capacity and (ii) MGO-modified apalbumin concentration of a honey sample, comprising the steps of:

a) measuring the fluorescence level of the honey sample,

b) determining the concentration of MGO-modified apalbumin (MMA) in the honey sample by:

comparing the fluorescence level of the honey sample to a standard scale that correlates fluorescence level to MMA-concentration, or

comparing the fluorescence level of the honey sample to fluorescence levels of one or more control samples of honey with known MMA-concentrations, and

c) determining the phagocytosis inhibition (PI) activity the honey sample by:

comparing the fluorescence level of the honey sample to a standard scale that correlates fluorescence value to PI-activity, or

measuring the PI-activity of the honey sample, and comparing the PI activity of the honey sample to PI-activities of one or more control samples of honey with known PI-activities,

wherein (b) identifies the concentration of the MGO-modified apalbumin in the honey sample and (c) identifies the anti-inflammatory capacity of the honey sample.

2. The method of claim 1 wherein the MGO-modified apalbumin is a modified apalbumin 1 protein (modified MRJP1).

3. The method of claim 1 , wherein the honey sample is obtained from a hive.

4. The method of claim 1 , wherein the honey sample is obtained from a stored honey.

5. The method of claim 1 , wherein one or more of the control samples of honey are manuka honey.

6. The method of claim 1 , wherein the fluorescence level is measured at an emission wavelength between 440-560 nm.

7. The method of claim 1 , wherein steps (a)-(c) are repeated after an interval of time, and wherein an increase in the fluorescence level and PI activity after the time interval is indicative of an increase in the anti-inflammatory capacity of the honey sample.

8. The method of claim 4 , wherein the stored honey has been incubated at 30-40° C.

9. The method of claim 4 , wherein the stored honey has been chemically treated with MGO, glyoxal, glutaraldehyde or a combination thereof.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2016
From: MANUKAMED LIMITED
To: WATSON & SON LIMITED
Reel/Frame 040754/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2016
From: WATSON & SON LIMITED
To: ORANGANUI LIMITED PARTNERSHIP
Reel/Frame 040754/0787 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2016
From: ORANGANUI LIMITED PARTNERSHIP
To: MANUKAMED HOLDINGS LIMITED PARTNERSHIP
Reel/Frame 040754/0806 →
CHANGE OF NAME Recorded Dec 22, 2016
From: ORANGANUI LIMITED PARTNERSHIP
To: WATSON & SON LIMITED PARTNERSHIP
Reel/Frame 041180/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2016
From: BEAN, AMANDA; MOLAN, PETER; CURSONS, RAY; WILKINS, RICHARD
To: MANUKAMED LIMITED
Reel/Frame 038942/0055 →
Priority Claims (1)
NZ 590143 · Dec 22, 2010 · national
Continuity (1)
Related Publication 20140154803A1 · Jun 5, 2014